Beyond Type 1: Focus on Access

Millions around the world with Type 1 struggle with issues of access, whether that be for economic, geographic or political reasons. Beyond Type 1 is committed to providing direct efforts and support for partners focused on issues of access, including access to basic supplies and life-saving medication, technology, devices and healthcare to optimize health, personal accounts and breaking news on global access issues and a wide variety of resources.

Life as a Refugee with Type 1 Diabetes

Life with Type 1 is full of ups and downs – and the stress of everyday life can test our ability to manage this chronic illness. Now imagine managing the disease in a war-torn country, or fleeing a conflict and facing new kinds of persecution as you seek refuge.

Half-Price Generics of NovoLog and NovoLog Mix Announced by Novo Nordisk

Novo Nordisk announced that authorized generic versions of NovoLog and NovoLog Mix will be made available on January 2, 2020.

Senate Bill Aims to Cut Price of Insulin by 75%

The "Insulin Price Reduction Act" would create a new pricing model for insulin, incentivizing manufacturers to lower list prices to 2006 prices.

New Guidance from the US Treasury Opens Door to High Deductible Exemptions for Diabetes Care

The U.S. Treasury issued new guidance which aims to make accessing medications for chronic conditions easier under some insurance plans.

Find The Devices You Need: DiabetesWise

DiabetesWise is dedicated to helping those living with diabetes discover the best devices to live their desired lifestyle.

New Senate Bill Would Speed up Availability of Generic Insulin in the U.S.

The Affordable Insulin Approvals Now Act is a bipartisan bill intended to speed up the approval process of generic insulins in order to help lower costs.

JDRF Advocates Urge Congress to Renew Funding for T1D Research

On the final day of the 2019 JDRF Children's Congress, advocates implored the U.S. Special Committee on Aging to renew the Special Diabetes Program.

One on One With Insulet CEO Shacey Petrovic

Insulet CEO Shacey Petrovic spoke with Beyond Type 1 about her personal connection to T1D, the importance of access, the future of Omnipod and more.

Help Emilia: A T1D Cause

Neil Greathouse asks other willing and able T1Ds to send extra supplies so that he might bring them down to Peru to help better (and possibly save) the life of a fellow T1D.

I Was Blamed for My T1D Diagnosis

Edith Mukantwari is President of the Africa Diabetes Alliance, an organization in Uganda that seeks to encourage diabetes education and bridge the information gap.

Colorado Becomes First State to Pass Bill Capping Insulin Costs

On Wednesday, May 22, Colorado became the first state in the U.S. to put a price cap on insulin.

Express Scripts Won’t Cover Lilly’s Generic Insulin

The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication.

Insulin Manufacturers and PBMs Testify Before Congress

The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.

Cigna Plan Could Cap Insulin Costs at $25 a Month

Cigna and Express Scripts announced on Wednesday that they would be lowering the out-of-pocket cost of insulin for some patients with diabetes.